0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Athlete's Foot (Tinea Pedis) - Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-021
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Athletes Foot Epidemiology Forecast to 2028

Athlete's Foot (Tinea Pedis) - Epidemiology Forecast to 2028

Code: DELV-Epid-021
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Athlete's Foot (Tinea Pedis) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Athlete's Foot (Tinea Pedis) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Athlete's Foot (Tinea Pedis) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Athlete's Foot (Tinea Pedis) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Athlete's Foot (Tinea Pedis) outlook. It also includes the explanation of changing trends of epidemiology outlining the Athlete's Foot (Tinea Pedis) scenario.

Athlete's Foot (Tinea Pedis) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Athlete's Foot (Tinea Pedis) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Athlete's Foot (Tinea Pedis) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Athlete's Foot (Tinea Pedis) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Athlete's Foot (Tinea Pedis)

Key assessments
• Patient Segmentation in Athlete's Foot (Tinea Pedis)
• Athlete's Foot (Tinea Pedis) Risk & Burden
• Factors driving growth in a specific Athlete's Foot (Tinea Pedis) patient population

1. Report Introduction
2. Athlete's Foot (Tinea Pedis) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Athlete's Foot (Tinea Pedis) in 2016
2.2. Patient Share Distribution of Athlete's Foot (Tinea Pedis) in 2028
3. Disease Background and Overview: Athlete's Foot (Tinea Pedis)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Athlete's Foot (Tinea Pedis) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Athlete's Foot (Tinea Pedis) in 7MM – By Countries
5. Epidemiology of Athlete's Foot (Tinea Pedis) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis)
5.1.3. Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) *
5.1.4. Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) *
5.1.5. Diagnosed Cases of the Athlete's Foot (Tinea Pedis)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis)
5.4.3. Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) *
5.4.4. Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) *
5.4.5. Diagnosed Cases of the Athlete's Foot (Tinea Pedis)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis)
5.5.3. Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) *
5.5.4. Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) *
5.5.5. Diagnosed Cases of the Athlete's Foot (Tinea Pedis)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis)
5.6.3. Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) *
5.6.4. Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) *
5.6.5. Diagnosed Cases of the Athlete's Foot (Tinea Pedis)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis)
5.7.3. Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) *
5.7.4. Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) *
5.7.5. Diagnosed Cases of the Athlete's Foot (Tinea Pedis)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis)
5.8.3. Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) *
5.8.4. Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) *
5.8.5. Diagnosed Cases of the Athlete's Foot (Tinea Pedis)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis)
5.9.3. Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) *
5.9.4. Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) *
5.9.5. Diagnosed Cases of the Athlete's Foot (Tinea Pedis)
6. Unmet Needs of the Athlete's Foot (Tinea Pedis)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in 7MM
Table 2: Total Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028) *
Table 14: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028)

List of Figures :

Figure 1: Total Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Athlete's Foot (Tinea Pedis) in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools

RELATED REPORTS

China Autogenous Vaccines Market Report Forecast 2021 2027
China Autogenous Vaccines Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-22Z1818
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Flu Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

In 2020 the global Flu Vaccine market size was US 5154 million and it is expected to reach US 7293.3 million by the end of 2027 with a CAGR of 4.8 during 20212027.Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-11H675
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global Rabies Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

And in terms of application the largest application is Postexposure Prophylaxis followed by Preexposure Prophylaxis.Market Analysis and Insights Global Rabies Vaccine MarketIn 2020 the global Rabies Vaccine market size was US 877 million and it is expected to reach US 1178 million by the end of 2027 with a CAGR of 4.0 during 20212027.Global Rabies Vaccin.

120 Pages
Type: Report
Code: QYRE-Auto-34M23
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global and United States Sulfachloropyridazine Sodium Market Insights Forecast to 2027
Global and United States Sulfachloropyridazine Sodium Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-28M6619
Tue Sep 21 00:00:00 UTC 2021

Add to Cart